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Free radicalsGlucose-stimulated insulin secretion (GSIS) by pancreatic β cells is regulated by mitochondrial uncoupling
protein-2 (UCP2), but opposing phenotypes, GSIS improvement and impairment, have been reported for
different Ucp2-ablated mouse models. By measuring mitochondrial bioenergetics in attached INS-1E
insulinoma cells with and without UCP2, we show that UCP2 contributes to proton leak and attenuates
glucose-induced rises in both respiratory activity and the coupling efﬁciency of oxidative phosphorylation.
Strikingly, the GSIS improvement seen upon UCP2 knockdown in INS-1E cells is annulled completely by the
cell-permeative antioxidant MnTMPyP. Consistent with this observation, UCP2 lowers mitochondrial reactive
oxygen species at high glucose levels. We conclude that UCP2 plays both regulatory and protective roles in β
cells by acutely lowering GSIS and chronically preventing oxidative stress. Our ﬁndings thus provide a
mechanistic explanation for the apparently discrepant ﬁndings in the ﬁeld.ntial; DAPI, 4′,6-diamidino-2-
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nse.© 2010 Elsevier Inc. Open access under CC BY license.Type 2 diabetes is a pandemicmetabolic disorder thatmanifests by
chronic hyperglycemia. Dysfunctional pancreatic β cells are involved
prominently in the etiology of this disorder, as they contribute heavily
to the impaired ability of diseased subjects to maintain glucose
homeostasis. In healthy subjects, β cells respond to rising blood
glucose levels by secreting insulin, which is a sign for peripheral
tissues such as skeletal muscle and liver to take up or store glucose,
respectively. When blood glucose levels rise, β cells increase their
oxidative catabolism of glucose, which leads to an increased
mitochondrial proton motive force and an increased cytoplasmic
ATP/ADP ratio. In the canonical model of glucose-stimulated insulin
secretion (GSIS)2, the boosted ATP/ADP poise closes plasmamembrane
KATP channels, causing plasma membrane depolarization, opening ofvoltage-sensitive calcium channels, calcium inﬂux, and insulin secretion
[1]. This order of events reﬂects an extraordinary bioenergetic design, as
the β cell's response to glucose implies that its ATP/ADP ratio is
controlled predominantly by ATP supply and not ATP demand, as is the
case in most other cell types [2]. Moreover, the outlined scenario
indicates that GSIS relies on the coupling efﬁciency of oxidative
phosphorylation, as it seems essential that glucose oxidation and
mitochondrial ATP synthesis are coupled tightly.
Pancreatic β cells contain a mitochondrial uncoupling protein,
UCP2 [3]. The generally anticipated molecular function of this protein
is partial dissipation of the proton motive force [4], which would
(mildly) uncouple oxidative phosphorylation. UCP2 activity is thus
expected to attenuate GSIS, a notion that is indeed supported by a
growing body of experimental evidence (reviewed in [5]). However, it
should be emphasized that a direct uncoupling function of UCP2 is not
accepted universally [6,7] and, furthermore, that studies into the
effects of UCP2 activity on GSIS are equivocal. Genetic knockout of
Ucp2 in mice was established originally on a mixed 129/SVJ×C57BL/6
background and resulted in greatly improved GSIS [3,8]. When this
Ucp2-ablated strain was backcrossed onto three different genetic
backgrounds, however, the GSIS phenotypewas lost completely [8]. In
fact, the resulting pure strains (C57BL/6 J, A/J, and 129/SvImJ) all
exhibited impeded GSIS, which has been attributed to the chronic
oxidative stress seen in these Ucp2 knockout animals [8]. Similarly,
the improved glucose tolerance reported by Zhang et al. [3] was not
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these discrepant observations that unambiguous interpretation of
studies with Ucp2-ablated mice is difﬁcult given the confounding
effects of genetic background. Such interpretation is complicated
further by likely secondary or systemic effects caused by the
ubiquitous and persistent absence of UCP2 protein from knockout
animals. The inconsistent effect of Ucp2 knockout on GSIS in different
mouse strains, for example, may partly be due to the chronic lack of
UCP2 in macrophages [10] and pro-opiomelanocortin neurons [11].
The ab initio absence of UCP2 in these tissues may well have
differentially affected, respectively, the immune status and the
hypothalamic glucose sensing ability of the various animal strains.
Interpretational difﬁculties of whole-animal studies can be
avoided by using less complicated experimental systems such as
clonal β cells. The relative strength of such a cellular approach is
highlighted by our previous studies with INS-1E insulinoma cells [12–
14], a widely used β-cell model that has retained most important
characteristics of primary β cells, including GSIS [15]. We have shown
that acute siRNA treatment of INS-1E cells can lead to 80–90%
knockdown of UCP2 protein within 48 h of transfection [13,14]. This
relatively acute knockdown of UCP2 protein causes a marked
improvement in GSIS [13], which agrees well with the original Ucp2
knockout studies in mice [3]. Our RNAi experiments furthermore
revealed that UCP2 contributes signiﬁcantly to the exceptionally high
mitochondrial proton leak activity of INS-1E cells [13]. This ﬁnding led
us to the assertion that UCP2 regulates the canonical GSIS pathway
through modulating the coupling efﬁciency of oxidative phosphory-
lation [5,13,14], a notion that has indeed been put forward by many
others (e.g., [3,16–18]). In light of the recent observation that
hydrogen peroxide is an important noncanonical GSIS signal [19,20],
however, we decided to explore the possibility that UCP2 activity
affects GSIS by modulation of mitochondrial reactive oxygen species
(ROS).
In this paper we report that the improvement of GSIS observed
upon UCP2 knockdown in INS-1E cells is completely annulled in the
presence of the cell-permeative antioxidant MnTMPyP. We show
furthermore that UCP2 knockdown in attached INS-1E cells lowers
mitochondrial respiratory activity, ampliﬁes a glucose-induced
increase in mitochondrial coupling efﬁciency, and, unexpectedly,
improves the cells’ respiratory response to glucose. Importantly, we
demonstrate that UCP2 activity lowers hydroethidine (DHE) oxida-
tion at high glucose levels, but only when this ROS probe is targeted to




INS-1E cells were obtained from Pierre Maechler and Claes
Wollheim (Department of Internal Medicine, University Medical
Center, Geneva, Switzerland) and grown as reported previously [15]
in RPMI medium containing 11 mM glucose and 2 mM glutamine. An
80–90% knockdown of UCP2 proteinwas accomplished through siRNA
transfection of INS-1E cells grown on XF24 (Seahorse Bioscience) or
96-well (Costar 3595; Corning) tissue culture plates. We have
previously conﬁrmed this level of UCP2 knockdown by Western
analysis [14] and have also shown that such knockdown is achieved
with siRNA oligonucleotides targeted at three different Ucp2 exons
[13]. Cells were grown overnight after seeding to about 50%
conﬂuence, transfected with 200 nM Ucp2-targeted siRNA (prede-
signed by Ambion, Huntingdon, UK; see [14]) in complex with 1.7 μg/
ml Lipofectamine (Invitrogen, Paisley, UK), and subjected to GSIS,
bioenergetic, and ROS assays 48 h posttransfection. To identify
potential nonspeciﬁc effects, control cells were transfected in parallel
with 200 nM scrambled siRNA (Silencer Negative Control 1; Ambion).GSIS
Cells seeded (at 40,000 cells per well) and transfected on 96-well
plates were starved for 2 h in RPMI that lacked glucose and pyruvate
and contained only 1% (v/v) fetal calf serum (FCS). Cells were washed
twice with a glucose-free Hepes-buffered Krebs–Ringer medium
composed of 135 mM NaCl, 3.6 mM KCl, 10 mM Hepes (pH 7.4),
0.5 mMMgCl2, 1.5 mM CaCl2, 0.5 mM NaH2PO4, 2 mM glutamine, and
0.1% (w/v) bovine serum albumin (KRH). Cells were then incubated in
KRH±20 μM MnTMPyP (a cell-permeative superoxide dismutase
mimetic [21]) for 30 min at 37 °C using a shaking plate incubator
(Labnet International, Oakham, UK) set at 100 rpm. Note that
metalloporphyrins such as MnTMPyP generally scavenge not only
superoxide but, to different extents, also hydrogen peroxide,
peroxynitrite, and lipid peroxyl radicals [21]. Next, the medium was
replaced with KRH containing 2, 5, or 30 mM glucose, again in the
presence or the absence of 20 μM MnTMPyP. After another 30-min
shaking incubation at 37 °C, the medium was collected and centri-
fuged to pellet any detached cells. Supernatants were assayed for
insulin by ELISA (Mercodia, Uppsala, Sweden) using mouse insulin as
a standard. Note that our KRH formulation contains 2 mM glutamine
to maintain UCP2 protein levels in control cells (cf. [22]), but lacks the
usually included sodium bicarbonate to prevent alkalinization of the
medium during the assay.
Mitochondrial bioenergetics
In experiments designed to measure bioenergetic parameters
under conditions identical to those applied during GSIS assays
(Figs. 2 and 3), cells were seeded (40,000 cells/well) and transfected
on Seahorse XF24 plates. On the day of assay, the cells were starved
for 2 h in RPMI that lacked glucose and pyruvate and contained only
1% (v/v) FCS. The cells were washed twice with glucose-free KRH
and incubated in this medium±20 μM MnTMPyP for 10 min in a
37 °C air incubator. The XF24 plate was then transferred to a
temperature-controlled (37 °C) Seahorse analyzer and subjected to a
10-min equilibration period and 3 assay cycles, comprising a 1-min
mix, 2-min wait, and 3-min measure period each (cf. [14]); then
glucose (2, 5, or 30 mM in KRH) was added by automatic pneumatic
injection. After 10 further assay cycles, oligomycin (1 μg/ml) was
added to inhibit the ATP synthase and thus approximate the
proportion of respiration used to drive ATP synthesis (coupling
efﬁciency). Each experimental trace was ended by addition of a
rotenone (1 μM) and myxothiazol (2 μM) mixture to determine the
nonmitochondrial respiratory rate, which was subtracted from all
other rates. The stated inhibitor concentrations gave maximum
effects as veriﬁed by doubling the concentrations. Coupling
efﬁciency was calculated as the oligomycin-sensitive fraction of
glucose-stimulated mitochondrial respiratory activity (last rate
before oligomycin addition). The mitochondrial respiratory response
to glucose was normalized as the ratio of glucose-stimulated and
basal oxygen uptake activities (last rates before oligomycin and
glucose addition, respectively).
In experiments designed to determine absolute oxygen consump-
tion rates (Fig. 1), cells were also seeded (20,000 cells/well) and
transfected on XF24 plates. On the day of assay (i.e., 48 h post-
transfection), however, the cells were not starved of glucose in RPMI,
but incubated instead for 1 h in a 37 °C air incubator in KRH
containing 2 mM glucose but lacking bovine serum albumin. After a
10-min equilibration in the Seahorse analyzer and 4 assay cycles to
measure basal respiration, the cells were subjected to 30 mM glucose.
In parallel experiments, either oligomycin (1 μg/ml) or a mixture of
oligomycin (1 μg/ml), rotenone (1 μM), and myxothiazol (2 μM) was
added after 10 further cycles to allow assessment of coupling
efﬁciency and nonmitochondrial respiratory activity, respectively
(see the Fig. 1 legend for more detail). Immediately after the Seahorse
Fig. 1. UCP2 knockdown lowers mitochondrial respiratory rate and increases the coupling efﬁciency of attached INS-1E cells. (A and B) Time-resolved absolute respiratory rates (Jo),
normalized to cell number as measured by nuclear staining, of cells transfected with Ucp2-targeted (closed symbols) or scrambled siRNA (open symbols) and treated as described under
Experimental procedures. After fourSeahorse assay cycles at 2 mMglucose, cellswere subjected to30 mMglucose (G30) and, inparallel experiments, either oligomycin (O) or amixture of
oligomycin, rotenone, andmyxothiazol (ORM). Each time point represents the average±SEM (n=8–12) of 8–12 separate wells sampled from seven independent Seahorse XF24 plates.
(C) Respiratory rates in the presence of the oligomycin/rotenone/myxothiazolmix were averaged and subtracted from all other rates to yieldmitochondria-speciﬁc respiratory activities.
Glucose-stimulated activity (G30) is the average of the last two rate measurements before oligomycin addition, and the oligomycin-insensitive activity (oligomycin) is the average of the
two rates after this addition. (D) Coupling efﬁciencies were calculated as the fraction of glucose-stimulatedmitochondrial oxygen uptake that is sensitive to oligomycin and thus reﬂects
respiratory activity used to drive ATP synthesis. The data in (C) and (D) are averages±SEM (n=13–15) of 13 (scrambled siRNA, open bars) or 15 (Ucp2-targeted siRNA, shaded bars)
separate wells sampled from seven independent XF24 plates. *pb0.05.
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nuclear DNA was then stained with 4′,6-diamidino-2-phenylindole
(DAPI; applied at a 1:5000 dilution). DAPI-stained cells were imaged
using a wide-ﬁeld microscope (10× magniﬁcation) and view ﬁelds
were assembled to construct images of individual XF24 wells. Cells
(nuclei) were counted using Image Analyst software (http://www.
imageanalyst.net) and speciﬁc oxygen consumption rates were
calculated as nanomoles atomic oxygen consumed per minute per
106 cells.ROS production
Cells seeded (40,000 cells/well) and transfected on 96-well plates
were starved for 2 h in RPMI that lacked glucose and pyruvate and
contained only 1% (v/v) FCS. The cells were washed twice with
glucose-free KRH and incubated in this medium±20 μM MnTMPyP
for 30 min at 37 °C using a shaking plate incubator (Labnet
International) set at 100 rpm. After these two glucose-starvation
periods that were identical to the experimental GSIS conditions, the
medium was replaced with KRH containing 2, 5, or 30 mM glucose,
again in the presence or the absence of 20 μM MnTMPyP, and either
5 μM MitoSOX (Invitrogen M36008) or 100 μM DHE (Invitrogen
D11347) was added. Plates were transferred immediately to a
spectroﬂuorimetricmicroplate reader (Molecular Devices Spectramax
Gemini XPS) and ﬂuorescence was recorded without mixing at 28-s
intervals for 1 h. Fluorescent oxidation products were excited at
510 nm and light emission was recorded at 580 nM (MitoSOX) or
610 nm (DHE).Statistics
Statistical analysis was performed with GraphPad Prism version
5.0a for Mac OS X (GraphPad Software, San Diego, CA, USA; www.
graphpad.com). All mean differences between experimental systems
and conditions were evaluated by one-way ANOVA with Tukey's
posttest, except for the difference shown in Fig. 1D, which was
assessed by an unpaired t test. The level of statistical signiﬁcance is
indicated in the ﬁgures by asterisks.
Results
We have reported previously that knockdown of UCP2 by RNAi
leads to improved GSIS in INS-1E insulinoma cells [13]. To assess the
bioenergetics of INS-1E cells under conditions identical to those
applied during the GSIS experiments, we used a Seahorse extracellular
ﬂux analyzer (cf. [14]) that enables noninvasive, real-time determi-
nation of mitochondrial respiratory activity and coupling efﬁciency in
attached cells. This approach is superior to our previous bioenergetic
assessment of trypsinized INS-1E cells [13] as it removes the concern
that the UCP2 knockdown phenotype is facilitated by a trypsin-
induced stress response.
UCP2 knockdown lowers mitochondrial respiratory activity of attached
INS-1E cells
Figs. 1A and 1B present time-resolved absolute respiratory
activities exhibited by attached INS-1E cells that were transfected
with scrambled or Ucp2-targeted siRNA and that had been starved for
Fig. 2. UCP2 knockdown improves GSIS in a MnTMPyP-sensitive manner, ampliﬁes a
glucose-induced rise in coupling efﬁciency, and improves the cells’ respiratory response
to glucose. Cells transfected with Ucp2-targeted or scrambled siRNA (shaded and open
bars, respectively) were ﬁrst starved of glucose as described under Experimental
procedures and then subjected to glucose in the absence (G2, G5, G30) or presence (G5-
PyP, G30-PyP) of 20 μM MnTMPyP; G2, G5, and G30 reﬂect 2, 5, and 30 mM glucose,
respectively. (A) Insulin secretion data are averages±SEM of four independent
experiments with each condition assayed six times. (B) Mitochondrial coupling
efﬁciencies and (C) the respiratory responses of the cells to glucose are averages±SEM
of 4–11 separate XF24 runs. These bioenergetic parameters were calculated from
Seahorse traces as described under Experimental procedures. **pb0.01 and ***pb0.001.
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glucose and lacking bovine serum albumin. After four basal rate
measurements, the glucose concentration was raised to 30 mM and,
in parallel experiments, the ATP synthase (Fig. 1A) and also the
mitochondrial respiratory chain (Fig. 1B) were subsequently inhib-
ited, respectively, by oligomycin or a mixture of oligomycin,
rotenone, and myxothiazol. Figs. 1A and 1B show that a raised
glucose concentration causes small respiratory increases in cells
with and without UCP2. Although these increases are relatively
modest and the respiratory rates are somewhat variable, it may be
noted that UCP2-containing cells achieve, relatively rapidly, an
activity that is steadier than that exhibited by UCP2-lacking cells. In
fact, glucose-stimulated cells without UCP2 do not reach a steady
respiratory rate until other effectors are added (cf. the normalized
respiratory responses to glucose shown in Fig. 2C). As expected,
oxygen uptake is lowered both by oligomycin (Fig. 1A) and by the
mix of oligomycin, rotenone, and myxothiazol (Fig. 1B). Under all
conditions and at all time points, the absolute total respiratory
activity of UCP2-containing cells is higher than that of their UCP2-
ablated counterparts. Fig. 1C shows these respiratory activities
corrected for nonmitochondrial oxygen consumption and, although
statistically not signiﬁcant, it can be seen that UCP2 knockdown
tends to lower mitochondrial respiration at 30 mM glucose both in
the absence and in the presence of oligomycin. This ﬁnding is
consistent with our previous study with trypsinized INS-1E cells [13]
and indicates that UCP2 activity stimulates mitochondrial proton
leak rate in attached INS-1E cells. The observation that nonmito-
chondrial respiration is decreased by UCP2 knockdown as well
(Fig. 1B) is again consistent with the trypsinized cell data, although
the nature of this effect remains unclear. The absolute mitochondrial
respiratory activities shown in Fig. 1C are about 70–80% higher than
the “trypsinized” activities [13], which is most probably due to a
different experimental design in terms of assay medium composition
and glucose concentration. The rate-lowering effect of UCP2
knockdown is more pronounced in the presence than in the absence
of oligomycin (Fig. 1C), which is reﬂected by the comparatively high
coupling efﬁciency of UCP2-depleted cells (Fig. 1D). Note that the
effect of UCP2 knockdown on coupling efﬁciency (a normalized
parameter) is indeed statistically signiﬁcant.
We stress that we deﬁne coupling efﬁciency as the proportion of
mitochondrial respiration that is used to drive ATP synthesis, i.e., the
respiratory fraction that is sensitive to oligomycin. In principle,
therefore, an increased coupling efﬁciency could be due to either
decreased proton leak rate or increased rate of ADP phosphorylation.
A lowered proton leak rate would decrease respiration, whereas a rise
in phosphorylation rate would increase it. UCP2 knockdown results in
both an increased coupling efﬁciency (Fig. 1D) and a decreased
mitochondrial respiratory activity (Fig. 1C), demonstrating that
knockdown of UCP2 is associated with decreased proton leak rate
across the mitochondrial inner membrane.
UCP2 dampens a glucose-induced increase in the coupling efﬁciency of
INS-1E cells
Next, we probed coupling efﬁciencies in attached cells under
conditions that were identical to those applied during the GSIS assay.
First, we performed a static GSIS experiment challenging glucose-
starved INS-1E cells with and without UCP2 with 2, 5, and 30 mM
glucose. The GSIS data shown in Fig. 2A reafﬁrm that acute UCP2
knockdown increases insulin secretion signiﬁcantly at 30 mM
glucose, whereas it does not affect insulin release at low glucose
levels. This GSIS improvement is somewhat more pronounced than
reported previously [13], which is probably due to the presence of
glutamine in all our current buffers to ensure that UCP2 protein is
retained in the control cells throughout the assay [22]. In parallel
experiments, we then determined the effects of glucose challenge onthe mitochondrial bioenergetics of starved INS-1E cells with and
without UCP2. Fig. 2B shows that a rise in glucose concentration
from 2 to 30 mM increases the coupling efﬁciency of UCP2-
containing cells from 0.13 to 0.32 on average. This increase is
more signiﬁcant in UCP2-depleted cells, leading to a coupling
efﬁciency of 0.41 on average at 30 mM glucose. It can be taken
from these data that UCP2 activity dampens a glucose-induced
increase in mitochondrial coupling efﬁciency. This outcome is
consistent with our previous conclusion that UCP2 attenuates GSIS
because of its considerable contribution to mitochondrial proton
leak [13].
613C. Affourtit et al. / Free Radical Biology & Medicine 50 (2011) 609–616UCP2 lowers the respiratory response of INS-1E cells to glucose
Figs. 1A and 1B show that the absolute respiratory activity of INS-
1E cells is increased modestly when the glucose concentration is
raised from 2 to 30 mM. The data shown in Fig. 2C were obtained in a
different set of experiments and quantify this respiratory effect by
normalizing glucose-stimulated activity to the basal activity mea-
sured in glucose-starved INS-1E cells with and without UCP2. When
glucose levels are kept low after the basal “starved” measurements
(i.e., when KRH with only 2 mM glucose is added), respiration in cells
with and without UCP2 declines gradually, leading to rates after 10
assay cycles that are approximately 70% of the initial activity (Fig. 2C,
G2). This respiratory decline may reﬂect the cells’ response to the
prolonged glucose deprivation. When UCP2-containing cells are
challenged with 5 or 30 mM glucose, the respiratory activity increases
to values that are, respectively, about 10 and 30% higher than the basal
activity (Fig. 2C, G5 and G30, open bars). Knockdown of UCP2
improves this normalized respiratory response, at both 5 and 30 mM
glucose, which leads to stimulated rates that are, respectively, about
25 and 70% above the basal rate (Fig. 2C, G5 and G30, shaded bars).
The improvement at 30 mM glucose is statistically signiﬁcant and it
can thus be concluded that, rather unexpectedly, UCP2 restrains a
glucose-induced increase in mitochondrial respiration. When the data
shown in Figs. 1A and 1B are normalized to basal mitochondrial
respiration, a similar, though somewhat less pronounced, UCP2
phenotype transpires (not shown). Variation in the size of the UCP2
effect is probably due to differences in experimental design,Fig. 3.MnTMPyP lowers the rate of MitoSOX oxidation by INS-1E cells. (A and B) Typical time
INS-1E cells that were not subjected to periods of glucose starvation. Traces are shown to illus
and assays that were performed in the presence of 15 μM antimycin A (squares), 15 μM F
MnTMPyP (B, triangles). Data are averages±SEM of 4–6 wells sampled from a single 96-w
MitoSOX oxidation rates in the presence (shaded bars) and the absence (open bars) of 20 μ
exempliﬁed in (A) and (B). Data are averages±SEM of 34–38 wells sampled from seven
MnTMPyP, respectively. (D) MitoSOX oxidation by nontransfected glucose-starved INS-1E c
G30, respectively) in the presence (shaded bars) and the absence (open bars) of 20 μMMnT
ﬂuorescence units. ***pb0.001.particularly with respect to glucose starvation before the respective
sets of measurements (see Experimental procedures).GSIS improvement upon UCP2 knockdown is annulled when ROS are
scavenged
In light of increasing evidence that ROS are important GSIS signals
[19,20], we explored the possibility that GSIS regulation by UCP2 is
affected not only by coupling efﬁciency but also bymitochondrial ROS.
To do this, we repeated the GSIS and bioenergetic experiments
described in the previous two paragraphs, but now in the presence of
MnTMPyP, a potent and cell-permeative antioxidant [21]. Strikingly,
the UCP2 knockdown-mediated rise in insulin secretion seen at
30 mM glucose was fully annulled when ROS were scavenged by
20 μMMnTMPyP (Fig. 2A). This observation associates UCP2with ROS
in terms of GSIS regulation, but not in themanner suggested by Krauss
et al. [23], who reported a dose-dependent MnTBAP-induced
stimulation of insulin secretion by pancreatic islets. Because the effect
of MnTBAP, an antioxidant slightly less potent than MnTMPyP [21],
was observed exclusively in UCP2-containing islets, it was interpreted
as prevention of superoxide-mediated UCP2 activation [23]. Quite
differently, MnTMPyP does not affect GSIS by UCP2-containing INS-1E
cells (Fig. 2A). Instead, our data reveal that a lack of UCP2 protein can
be compensated for by the presence of a ROS scavenger and therefore
suggest that UCP2 activity attenuates GSIS, at least in part, by
dampening ROS levels.-resolved ﬂuorescence observed upon the oxidation of 5 μMMitoSOX by nontransfected
trate assays that were done without any effector (circles) or added probe (A, diamonds)
CCP (A, triangles), 20 μM MnTMPyP (B, diamonds), or 15 μM antimycin A and 20 μM
ell plate and, to aid clarity, symbols are shown only for every 10th measurement. (C)
M MnTMPyP were calculated from the slopes (after the ﬁrst 1000 s) of progress curves
plates and 18–22 wells sampled from four plates in the absence and the presence of
ells (see Experimental procedures) subjected to 2, 5, and 30 mM glucose (G2, G5, and
MPyP. Data are averages±SEM of 22–24 wells sampled from three plates. RFU, relative
614 C. Affourtit et al. / Free Radical Biology & Medicine 50 (2011) 609–616Importantly, the presence of 20 μM MnTMPyP during respiration
measurements with glucose-starved INS-1E cells has no effect on
either coupling efﬁciency (Fig. 2B) or normalized glucose-stimulated
respiration (Fig. 2C). The absolute value of these bioenergetic
parameters, in cells both with and without UCP2, is not signiﬁcantly
affected by ROS scavenging. The MnTMPyP insensitivity of the UCP2-
knockdown effect on the INS-1E coupling efﬁciency is somewhat
surprising, because the superoxide activation of UCP2-mediated
effects in pancreatic islets [23] had raised the expectation that
MnTMPyP would increase coupling efﬁciency of UCP2-containing
cells at 30 mM glucose.Fig. 4. UCP2 activity lowers mitochondrial ROS at high glucose levels. Cells transfected
with Ucp2-targeted (shaded bars) or scrambled (open bars) siRNA were ﬁrst starved of
glucose as described under Experimental procedures and then subjected to glucose in the
absence (G2,G5,G30)orpresence (G2-PyP, G5-PyP, G30-PyP) of 20 μMMnTMPyP;G2,G5,
and G30 reﬂect 2, 5, and 30 mM glucose, respectively. (A) MitoSOX (5 μM) oxidation
rates were obtained as described for Fig. 3 and (B) DHE (100 μM) oxidation rates were
calculated from the slopes of the ﬁrst 500 s of the ﬂuorescence traces. Data are averages±
SEM of 25–30 wells sampled from six 96-well plates. *pb0.05, **pb0.01 and ***pb0.001.MitoSOX oxidation by INS-1E cells
Although the MnTMPyP effect on GSIS in itself shows that this
chemical is active when added to INS-1E cells, we wished to establish
more directly that it scavenged ROS. If MnTMPyP indeed scavenges
ROS (including superoxide) in INS-1E cells, then it should lower the
rate of DHE oxidation, an activity that can be monitored ﬂuorime-
trically and that is widely used to detect superoxide in cultured cells
[24]. Note that DHE is oxidized not only by superoxide but also by
hydrogen peroxide (in the presence of peroxidases) and intracellular
oxidoreductases [24]. Fig. 3A shows several typical ﬂuorescence
progress curves that reﬂect the oxidation by INS-1E cells of MitoSOX, a
DHE derivative that is targeted to mitochondria because of its
conjugation to the lipophilic triphenylphosphonium cation. The
slope of these ﬂuorescence traces reports mitochondrial ROS [24], a
notion that is corroborated by the expected responses of MitoSOX
oxidation to antimycin A and the uncoupling agent FCCP, which
increase and decrease this slope, respectively (Fig. 3A). Similar traces
shown in Fig. 3B illustrate qualitatively that MnTMPyP lowers the rate
of MitoSOX oxidation both in the absence and in the presence of
antimycin A. This effect is statistically signiﬁcant only in the presence
of antimycin A (Fig. 3C), but demonstrates that MnTMPyP effectively
lowers ROS concentrations in the presence of MitoSOX. From this it
may be inferred that MnTMPyP indeed lowers (mitochondrial) ROS
levels in INS-1E cells. Furthermore, Fig. 3D shows that MnTMPyP
decreases MitoSOX oxidation rates at low and high glucose levels
when nontransfected INS-1E cells are subjected to conditions applied
during the GSIS experiments. Raising the glucose concentration from
2 to 30 mMmay increase ROS concentration slightly, but this effect is
statistically not signiﬁcant (Fig. 3D). It is clear from these data,
however, that theMitoSOX assay is well suited to assessing if and how
UCP2 knockdown affects mitochondrial ROS under GSIS-like
conditions.UCP2 knockdown effects on DHE oxidation
Fig. 4A shows that MitoSOX oxidation by transfected UCP2-
containing cells (scrambled control) does not change discernibly
when the cells are subjected to increasing glucose concentrations.
UCP2 knockdown results in a statistically signiﬁcant rise in the
MitoSOX oxidation rate at 30 mM glucose, which effectively means
that this rate tends to exhibit a glucose dependence in UCP2-ablated
cells. In other words, the data suggest that UCP2 activity prevents a
glucose-induced increase in mitochondrial ROS. Importantly, the
UCP2 knockdown-mediated increase in MitoSOX oxidation at
30 mM glucose is fully abolished in the presence of MnTMPyP
(Fig. 4A).
Unlike MitoSOX, DHE itself is not targeted to mitochondria. The
oxidation rate of DHE is unaffected by glucose concentration, in cells
both with and without UCP2 (Fig. 4B). Moreover, MnTMPyP does not
signiﬁcantly affect DHE oxidation at any glucose level, in cells neither
with nor without UCP2 (Fig. 4B).Discussion
The possibility that UCP2 might be a relevant GSIS regulator has
provoked considerable interest (see, e.g., [5,25–27] for reviews) as
this mitochondrial carrier could well be an attractive therapeutic
target in the treatment of type 2 diabetes. The various genetically
modiﬁed mouse models that have been established to explore this
possibility, however, exhibit inconsistent phenotypes: glucose toler-
ance and GSIS in the original Ucp2-deﬁcient mouse are improved [3],
whereas in more backcrossed strains they are unaffected [9] or
impeded [8]. Not surprisingly, these diametrically opposite observa-
tions have led to rather different suggestions for the in vivo function of
UCP2. On one hand, a pathological role in the etiology of type 2
diabetes has been suggested [26], and on the other, a physiological
role in the protection against oxidative stress has been proposed [27].
If UCP2 is to be considered a therapeutic target in type 2 diabetes, it
seems essential to shed light on these disparate ﬁndings. Our data
increase the understanding as to how GSIS is regulated by UCP2 and
thus provide mechanistic grounding for the apparently discrepant
ﬁndings in the ﬁeld. Because all our data were obtained using a clonal
β-cell model, obvious caution is warranted in their physiological
interpretation.
GSIS regulation by UCP2
Arguably our most striking observation is that GSIS improvement
after UCP2 knockdown is abolished by MnTMPyP (Fig. 2A), which
indicates that UCP2 attenuates GSIS by depressing ROS levels. This
result is consistent with the recent awareness that ROS are an
important signal during GSIS [19,20]. Pi and colleagues showed that
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insulin secretion at low glucose levels. Insulin secretion is also
increased by diethyl maleate, a compound that raises intracellular
H2O2 levels [20]. GSIS is inhibited by H2O2 scavengers, but is
unaffected by a cell-permeative superoxide dismutase [20]. In
agreement with these data, our UCP2-containing cells exhibit GSIS
that is insensitive to MnTMPyP (Fig. 2A). However, the MnTMPyP
sensitivity of UCP2-depleted cells indicates that H2O2 is not a relevant
signal during the GSIS that is facilitated by a lack of UCP2. ROS-
mediated GSIS attenuation by UCP2, therefore, probably occurs via a
mechanism (probably involving superoxide) different from the one
that accounts for the ﬁndings of Pi et al. [20].
INS-1E cells tend to exhibit glucose-stimulatedMitoSOX oxidation,
but only in the absence of UCP2 (Fig. 4A). Importantly, oxidation of
DHE not targeted to mitochondria is fully glucose insensitive even in
the absence of UCP2 (Fig. 4B). Moreover, MitoSOX oxidation is
decreased by MnTMPyP (Fig. 4A), which annuls the UCP2-dependent
difference seen at high glucose. Together, these data suggest that
UCP2 lowers GSIS by dampening glucose-induced ROS production.
Two points of caution, however, deserve attention.
First, MitoSOX equilibrates across the mitochondrial inner mem-
brane according to the Nernst equation and thus accumulates in a
membrane potential (Δψ)-dependent manner [24]. It is therefore
conceivable that the MitoSOX concentration achieved in mitochon-
dria lacking UCP2 is higher than that reached in their UCP2-containing
counterparts, based on the assertion that UCP2 activity partially
dissipates the Δψ. Because MitoSOX oxidation depends on probe
concentration (the dose dependency is linear up to 50 nM in cultured
neurons [28]), the UCP2 effect at 30 mM glucose (Fig. 4A) could
formally be due to a probe accumulation difference. This eventuality
seems unlikely, however, because we applied a saturating MitoSOX
concentration (5 μM). More importantly, UCP2 knockdown is not
expected to increase the Δψ exclusively at 30 mM glucose, but also
(perhaps even more so given the underlying kinetics of oxidative
phosphorylation [14]) at 2 and 5 mM glucose. MitoSOX oxidation at
these glucose levels is not affected signiﬁcantly by UCP2 knockdown
(Fig. 4A).
The second issue that requires attention is the apparent lack of
effect of UCP2 knockdown on DHE oxidation (Fig. 4B). Even without a
speciﬁc targeting moiety, DHE is expected to achieve concentrations
that are sufﬁcient to detect mitochondrial ROS. It is important to
appreciate in this respect that pancreatic β cells contain NADPH
oxidases that produce considerable amounts of cytoplasmic superox-
ide [29]. It should be realized too that DHE is oxidized not only by
superoxide but also by H2O2 (in the presence of peroxidases) and
intracellular oxidoreductases [24], which probably explains the
relative insensitivity of DHE oxidation to MnTMPyP (Fig. 4B). We
assert that DHE is mainly oxidized by cytoplasmic INS-1E events
(supported by insensitivity of DHE oxidation to antimycin A; data not
shown) that mask any effect UCP2 may have on mitochondrial ROS
production. MitoSOX oxidation, on the other hand, is dominated by
mitochondrial ROS because of the vast accumulation of this probe into
the mitochondrial matrix, which is evidenced by stimulatory and
inhibitory effects of antimycin A and FCCP, respectively (Fig. 3A).
The differential effect of UCP2 on MitoSOX and DHE oxidation
(Fig. 4) is readily interpreted as an exclusive effect of UCP2 on
mitochondrial ROS production. Our data do not explain how these ROS
stimulate GSIS. Presumably it is attenuation of the proton motive
force by UCP2 that lowers mitochondrial ROS production (Fig. 4) and
decreases the coupling efﬁciency of oxidative phosphorylation
(Fig. 2B). Decreased coupling efﬁciency attenuates glucose-induced
rises in the cytoplasmic ATP/ADP ratio. Further research is required to
quantify the relative importance of the UCP2 effects on ROS and ATP/
ADP in terms of GSIS regulation, although the full sensitivity to
MnTMPyP (Fig. 2A) suggests strongly that the UCP2 phenotype is
mediated mainly via ROS in our experiments. Interestingly, ourbioenergetic data disclose another novel mechanism by which
mitochondrial uncoupling may lower GSIS, as UCP2 activity also
dampens the cells’ respiratory response to glucose (Fig. 2C). It is
currently unclear how the self-reinforcement of glucose oxidation is
effected, but ROS, ATP/ADP, or Krebs cycle intermediates are all
possible signals. The MnTMPyP insensitivity of the UCP2 effect
(Fig. 2C), however, implies that mitochondrial ROS are the least likely
cue. The relative tardiness of the effect (Figs. 1A and 1B) indicates that
mitochondrial biogenesis may be required.
UCP2 function and regulation
Although the attenuating effect of UCP2 activity on glucose-
stimulated coupling efﬁciency (Fig. 2B) and mitochondrial ROS
production (Fig. 4) agrees with a primary proton leak function, it is
possible that a different UCP2 activity accounts for these phenotypes.
For example, putative pyruvate export by UCP2 [30] could explain in
principle how UCP2 dampens glucose-dependent respiration, ROS
production, and coupling efﬁciency, by oxidizing and slowing the
electron transport chain. However, measurements of absolute
respiratory activity in cells with and without UCP2 distinguish simply
between a proton leak and pyruvate export function. As demonstrated
before in pancreatic islets [31] and trypsinized INS-1E cells [13], UCP2
knockdown lowers the mitochondrial respiratory rates of attached
INS-1E cells, in the absence but particularly the presence of
oligomycin (Fig. 1C). This ﬁnding demonstrates that UCP2 contributes
to mitochondrial proton leak. If UCP2 exported pyruvate, then the
absolute respiratory activities would have increased upon UCP2
knockdown.
Previous work from our laboratory has led to the notion that UCPs
attenuate Δψ only when they are activated, for example, by
superoxide [32]. Although functional regulation of novel UCPs is the
subject of ongoing debate [6,7,33], some experimental evidence
supports UCP2 activation in cells. In thymocytes, for example, UCP2
activity is stimulated by the retinoic acid analogue TTNPB [34] and all
UCP2-mediated pathological effects in pancreatic islets depend on
superoxide [23]. However, our current data do not favor UCP2
activation in INS-1E cells by superoxide. ROS scavenging byMnTMPyP
in UCP2-containing INS-1E cells does not lead to improved GSIS
(Fig. 2A), coupling efﬁciency (Fig. 2B), or an increased normalized
respiratory response to glucose (Fig. 2C). Although MnTMPyP clearly
lowers mitochondrial ROS (Figs. 3B, 3C, 3D, and 4A), it remains
possible that the concentration we applied (20 μM) is insufﬁcient to
acutely reverse already activated UCP2. In that case, it would be
surprising that 10–20 μM MnTBAP prevents UCP2 activation in
pancreatic islets [23]. Similarly, INS-1E respiration is not affected
signiﬁcantly by TTNPB either, even when the compound is added in
the presence of oligomycin (C. Affourtit and M.D. Brand, unpublished
data). In our hands, TTNPB does in fact inhibit GSIS, but in a UCP2-
independent manner. Together with the recent observation that β-
cell UCP2 is not activated by fatty acids [35], our datamay suggest that
UCP2 activity is not regulated acutely in cultured β cells, perhaps
because the protein is permanently or constitutively activated. In that
case, activity in these cells would be controlled exclusively by
transcription and translation against a background of exceptionally
rapid UCP2 protein degradation [22].
Conclusion
Thework presented in this paper highlights the relative strength of
the INS-1E model, providing new insights into UCP2 function and
regulation. Importantly, we have shown that UCP2 attenuates GSIS in
a manner that can be mimicked by the antioxidant MnTMPyP. This
ﬁnding reafﬁrms that UCP2 is an acute regulator of GSIS, which agrees
with the GSIS phenotype exhibited by the original Ucp2-knockout
mouse [3]. Moreover, we have shown that UCP2 lowers mitochondrial
616 C. Affourtit et al. / Free Radical Biology & Medicine 50 (2011) 609–616ROS in INS-1E cells at high glucose concentrations. This particular
result provides a direct mechanistic basis for the oxidative stress
phenotype exhibited by the more recently established Ucp2-deﬁcient
mouse strains [8]. We conclude that through modulation of
mitochondrial ROS production, UCP2 plays both regulatory and
protective roles in pancreatic β cells as its activity will attenuate
GSIS acutely and, in the long term, will also prevent oxidative stress.Acknowledgments
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